Abstract. A non-technical review of the main developments of the last 10 years in mathematical modelling of tumour-induced angiogenesis is presented. This field has seen much progress in recent times, therefore, for the sake of concreteness and brevity, we will focus on hybrid models in which the progression of the vascular network, described in terms of individual-based models, is coupled to blood flow and/or external factors due to the dynamics of its sorrounding tissue. The interest of such models is twofold: whilst they constitute the state-of-the-art as far as (potential) predictive power and clinical applicability is concerned, their analysis and numerical implementation also offer remarkable mathematical challenges.
Introduction

Mathematical Biology
1 has experienced an spectacular growth in the last decade. Such growth has been driven by necessity. In the postgenomic era, Biology has been flooded by massive amounts of data. This has brought about a number of the socalled "OMICS" disciplines (eg genomics, proteomics, metabolomics, etc.) in an attempt to organise this flow of information into different layers and make sense of it. Fundamental to such attempts is the use of mathematical methods which constitute the foundations of Systems Biology and Bioinformatics.
This flow of information has also uncovered the fact that many biological processes, including many human diseases, are far more complex than it had been expected previously. This has lead to the realisation that the traditional attempts amongst biologists to formulate theories based on verbal models and lineal reasoning are essentially obsolete [GM] . A possible remedy to this situation is to formulate mathematical models of such complex systems, which, in turn, might help to formulate hypothesis as to how the particular system under eximination works, which should then be tested against and compared to experimental results.
A paradigmatic example of this situation is cancer. The term "cancer" is a heading under which a large number of different disorders is grouped. All these diseases share a common feature, namely, the control mechanisms maintaining homeostasis in normal tissue are bypassed and uncontrolled growth ensues [W] . This deregulation of normal control mechanisms affects and is influenced by processes occurring at all levels of biological organisation, which, physically, correspond to different time and length scales: from alterations in the patterns of gene regulation and expression to aberrant behaviour of whole tissues, such as abnormal elastic properties or pathological remodelling of the vasculature. This fact implies tha,t to understand cancer evolution and design efficient treatments, information from all these differents levels must be integrated into a unified conceptual framework.
A natural approach to achieve such description is the use of multiscale models, in particular hybrid models 2 [ABb, ABc] . Multiscale models in their hybrid incarnation consist of a hierarchy of models, each of them dealing with the processes relevant at a different scale. Each of these processes may be described using a different mathematical description, but the common denominator of all these models is the use of an individual-based model to deal with the "cellular phase" of the system. For example the multiscale model of vascular tumour growth developed in [ABc] uses ordinary differential equations (ODEs) to describe intracellular processes (cell cycle progression, apoptosis, etc.), a cellular automaton to describe cell-to-cell interactions and partial differential equations (PDEs) to describe diffusion of nutrients and signalling cues. A number of models based on this concept have been developed to analyse different aspects of tumour growth [A, DD, PG, SG] .
The present review concentrates in a particular but rather crucial step in the development of solid tumours: angiogenesis. Angiogenesis, the process whereby new vessels are generated from the existing vasculature, is thought to be one of the landmarks in tumour development. According to the usual picture of tumour development, which goes back to Folkman's seminal work [F] , a tumour starts off as a small lession whose cells obtain oxygen and other vital substances by diffusion accross its surface. Its size during this initial stage, the so-called avascular phase, is therefore limited by the diffusion rate of nutrients, typically to 1-2 mm in diameter [RC] . Thus, during this phase, tumours remain small and localised lessions and, consequently, deemed harmless. However at some point, cancer cells, under the stress of the lack of oxygen and other nutrients, start secreting a number of cytokines known as angiogenic factors [FK] , most importantly, the so-called vascular endothelium growth factor (VEGF). These cytokines diffuse through the tissue until they finally reach the vasculature of the host organism, which triggers activation of the endothelial cells 3 (ECs). Active ECs migrate chemotactically towards the source of angiogenic factor (i.e. the tumour) and start dividing. This marks the onset of the angiogenic process which culminates with the formation of a new vascular network which, in turn, provides the tumour with virtually endless 2 This term is often used in a loose and rather imprecise way. For example, the angiogenesis model of Anderson and Chaplain [AC] to be described in Sec. 3 is sometimes presented as a hybrid model. This model is an individual-based model based on an approach which combines continuous and discrete approaches in a particular way. It therefore would not fall within the category of hybrid models as we define them here.
3 Endothelial cells are the cells that line the vessels of the vascular system resources and unbound growth ensues. In addition to this, malignant cells are shed by the tumour into the circulation. These cells eventually extravasate, and start colonies in remote parts of the host organism called metastasis, which is, in fact, the primary cause of mortality in cancer patients [CG] . Angiogenesis, therefore, would appear to mark the transition from a tumour being a loclaised, harmless lession to it becoming a systemic, potentially fatal disease. It was suggested by Folkman [F] that anti-angiogenic therapy, whereby the tumour would be deprived of the vascular network supplying it with oxygen and other vital metabolites, should starve the tumour, shrinking it to a harmless size. Such hypothesis has been extensively confirmed by in vitro experiments and mice models. However, in spite of the success in laboratory experiments and animal models, anti-angiogenic therapies have fared very poorly when in clinical trials on human patients with extremely modest results (see [Jb] and references therein for a full account). The reasons for this failure are far from clear, specially concerning the explanation of why anti-angiogenic drugs are efficient in mice but not in humans.
In view of this state of affairs, new avenues are beginning to be explored in relation with combination of anti-angiogenic and conventional therapies (i.e. cytotoxic drugs and radiotherapy). It has been observed that when chemo-or radio-therapy are appropriately combined with antio-angiogenic drugs, the later notably increases the efficiency of the former [Jb] : a few days after anti-angiogenic therapy is administered, a period of time, the so-called window of opportunity, opens such that if conventional therapy is administered, its efficiency is greatly increased within this time window. The mechanisms for this phenomenon are, again, largely unknown, although there is strong evidence pointing towards vessel normalisation to be reponsible for it.
Tumour vasculture has very different properties from its normal counterpart. In fact, whereas "normal" vasculature has a very definite anatomical structure and a very regular spatial distribution to ensure no portion of tissue receive insufficient supply of nutrients, tumour vasculature lacks most of these properties: it is immature, structurally unstable and spatially disorganised. Anti-angiogenic drugs seem to partly remediate these anomalies to produce a more normal-looking vasculature. Such normalisation contributes to create a more uniform supply of oxygen and drugs, which yields an increase in their efficiency [Jb] .
This discussion illustrates that we are looking at a complex problem which needs to be examined from an integrative perspective to achieve a proper understanding. Angiogenesis is, therefore, a very complex sequence of well-orchestrated steps involving sprouting, chemotactic cell migration, proliferation, sprout fusion and maturation, leading to onset of blood flow, and complex interactions with the surrounding tissue [R, Ja, Jb] . It thus offers a natural ground for the application of the hybrid modelling methods described in previous paragraphs. The present chapter is devoted to review advances in angiogenesis modelling using the hybrid approach. For the interested reader, other aspects of cancer modelling have been dealt with at length in other topical or general reviews. A general review of several topics in mathematical approaches to tumour growth may be found in the book edited by Preziosi [P] . More recent developments have been reviewed in [BA] . For an excellent review of angiogenesis modelling, mostly dealing with earlier work but with some overlap with the present chapter, see reference [MW] . Roose et al present a review of avascular tumour modelling in [RC] . The use of cellular automata in Biology and, in particular, in tumour growth, has been reviewed in [CG] and [MD] , respectively. It must be remarked that the aim of this paper is to illustrate the different approaches to modelling tumour-induced angiogenesis by means of a collection of selected examples, rather than producing an exhaustive review of the literature on the subject.
This chapter is organised as follows. Section 2 presents a brief biological summary of angiogenesis. Section 3 is devoted to review individual-based models of network formation. Section 4 deals with models of blood flow and vascular adaptation, leading to a discussion of how the complexities involved in blood flow through the microvasculature produce a heterogenous microenvironment and imposes barriers to drug delivery. In Section 5 , we introduce the issue of cooption-induced vessel dematuration and collapse and the models attempting to study its effects of tumour growth and its therapy. Section 6 presents models which include a dynamic coupling between angiogenesis and vascular adaptation. Finally, we present our conclusions in Section 7.
Brief introduction to the biology of angiogenesis
Angiogenesis is part of the homeostatic mechanisms in place to maintain tissue well-oxygenated in response to acute increase in metabolic demands, and as such is part of many physiological, normal processes [C] . In fact, the vascular system is the first organ to be formed during development, a process called vasculogenesis, which is different from, but related to, angiogenesis that has been the object of a number of mathematical models [ABe, Me, MG, MB, SP] .
Hypoxia (i.e. oxygen starvation) is a major factor in triggering angiogenesis. When solid tumours grow beyond some point, the existent vasculature is unable to supply it with the oxygen and other substances it needs to keep on growing, extensive regions within the tumour become hypoxic. In response to such stress, cancer cells secrete and release a number of signalling molecules, the so-called tumourangiogenesis factors (TAFs), in particular a cytokine called VEGF which has potent angiogenic effects [BB, PR] 4 . TAFs secreted by tumour cells under metabolic stress (e.g. hypoxia) are released into the tissue where they diffuse to eventually reach the pre-existent vasculature. On receiving the corresponding stimulus, ECs lining these vessels are activated and a complex series of events ensues. One of the earliest of these events seems to consist of ECs activating their proteolytic machinery, i.e. the pathways which regulate the ability of the cell for protein degradation, being activated [PBa, PBb] , which appears to be a fundamental step in helping the angiogenenic process. ECs need to degrade the basement membrane in order to pass into the surrounding tissue. Once the ECs have entered the sorrounding tissue, they are able detect gradients of TAF and respond chemotactically, migrating towards the source of angiogenic factor (i.e. the tumour), thus forming cords of ECs [C] . In addition to the chemotactic reponse, EC migration has been recently shown to be also dependent upon the activation of the proteolyitc machinery, which degrades the extracellular matrix of the tissue, thus facilitating EC movement [PBb] 5 . During their migration towards the tumour, some of these cords meet and fuse with each other. This process of cord fusion is called anastomosis and is the first step towards a functional vascular bed.
The aforementioned process generates a proto-vascular 6 network, which does not aleviate the physiological stress on the tumour, as it is not circulated by blood and, therefore, is not supplying the tumour with any nutrients. Before becoming a functional network, a few steps must still be accomplished. These steps involve capillary strand and tube formation, which, eventually, leads to the establishment of blood flow.
Stabilisation of this nascent vasculature is a very complex process with a number of different signalling pathways involved. It appears, however, that, in both vasculogenesis and physiological angiogenesis, such stablisation depends upon recruitment of mural cells (i.e. cells belonging to the wall of blood vessel) and generation of extracellular matrices, which trigger survival signals within the ECs and contribute towards preventing vessel collapse [C, Ja] .
Another system that is critical for vessel maturation in embryonic vasculogenesis is the Tie receptors, Tie1 and Tie2. The corresponding ligands are the angiopoietins, Ang1 and Ang2. These two ligands are secreted by the mural cells and the ECs, respectively. Ang1 stabilises new vessels and makes them leak-resistant, possibly by facilitating the interaction between ECs and mural cells although the mechanisms by which Ang1 acts are largely unknown 7 . The effects of Ang2 appear to depend upon the actual environment: in the presence of VEGF, Ang2 promotes sprouting and, thus, angiogenesis. When VEGF is absent, Ang2 acts as an antagonist of Ang1, destabilising the vessel and promoting collapse. Many of the mechanisms involved in physiological angionesis, as it occurs, for example, in wound healing, are similar to those occurring in embryonic vasculogenesis. However, the different environment, as produced, for example, by low pH and abnormal hydrostatic pressure or shear stress, may remarkably influence the formation, maturation and remodelling of angiogenic vessels.
Abnormal vessel maturation in tumour angiogenesis.
8 Most of the process described above is common to physiological (normal) and pathological angiogenesis, specially those concerning its earliest stages. However, as far as vessel maturation is concerned, normal and tumour angiogenesis differ greatly. In fact, abnormal vasculature is one of the hallmarks of solid tumours [Ja] .
Tumour vasculature presents abnormalities with respect to its normal counterpart at all levels of organisation and function. Whereas the normal vasculature has a well structured, hierarchical organisation, tumour vessels are organised in a chaotic fashion. This has a number a consequences specially regarding transport of oxygen and other nutrients and metabolites to the tissue. In normal tissue no cell is 5 Tissue degradation by activation proteolysis appears to play a major role in other stages of the development of solid tumours, such as invasion. See [CLa, CLb] for detailed reviews and models.
6 The term proto-vessel to refer to these uncirculated, immature cords of ECs was (unofficially) coined by Markus Owen.
7 For example, in absence of mural cells, upregulation of Ang1 is enough to produce normal vessels [Ja] .
8 Here we give a brief summary of this important issue. The interested reader is referred to the reviews [YD, Ja, Jb] and references therein for a more detailed account.
farther apart from any vessel by a distance superior to the oxygen diffusion length, which imposes a uniform distribution of the size of the spaces between vessels. In cancerous tissue, such distribution of sizes does not follow such a regular pattern, which leads to extensive hypoxic areas within the tissue.
ECs in tumour vessels lack common endothelial markers and exhibit disregulation of expression of a number of genes, in particular those corresponding to adhesion molecules. As a consequence, tumour vasculature also lacks the normal wall structure whereby ECs do not line perfectly with wide junctions in some regions. Mural-cell coverage of the vessels seems to be impaired. All these factors contribute towards tumour vessels being immature, leaky and prone to collapse.
To make the situation even worse, as has been mentioned in the Introduction, solid tumours appear to have the ability of, as it grows and engulfs the native, originally normal vasculature, reversing the maturation process. As the tumour invades the normal tissue and co-opts the normal vasculature in place, vessels, sensing inappropriate co-option, start expressing autocrine Ang2. According to the picture drawn in previous paragraphs, this increase in the levels of Ang2 triggers apoptotic death in the vessels, thus producing vascular regression. Such regression leads to the development of hypoxic regions within the tumour and, consequently, to the secretion of VEGF which, together with high Ang2 levels, triggers the onset of angiogenesis. In addition, due to the fact that the levels of Ang2 stay high, the resulting vessels fail to mature normally, leading to a defective vasculature as the one described in the previous paragraphs.
Models of network formation based on random tip motion
Broadly speaking, the models we deal with in this section correspond to the earliest stages of the angiogenic processes, i.e. to the generation of a network of uncirculated proto-vessels as described in Section 2. In other words, these models generate the skeleton of the network, without dealing with issues such as blood flow or transport of oxygen to the tissue.
These models share a common structure, schematically represented in Fig. 1 . The basic ingredient of such models is an individual-based model of the random movement of a point, reffered to as tip, on a lattice. This tip represents the ECs at the leading edge of a growing vessel. Its random walk on the lattice is biased according to several stimuli (which, in biological terms, correspond to VEGF concentration, ECM concentration, etc) spatially distributed over the lattice. The trail left behind by the tip (defined as the locus of lattice sites visited by the tip) is identified with the vessel. This type of model has its precendents in the stochastic model of EC response to chemotactic cues by Stokes & Lauffenburger [SL] and the models of reinforced random walks [OS] .
3.1. The continuous-discrete approach of Anderson & Chaplain. The first example of this sort of model we discuss is presented in [AC] in which the so-called continuous-discrete approach is introduced. The core of this model, as we have already mentioned, is the biased random walk of the tip of the vessel. In this model, the movement of the tip is modulated by two factors: the gradient of TAF and the gradient of adhesivity.
In every individual-based model (IBM) some rules for the time evolution of the system must be defined. These rules dictate how the state at time t + ∆t depends on the state of the system at time t. The way in which these rules for the dynamical In the plot the tumour is assumed to at the top and a vessel within the organism native vasculature is at the bottom. The grid represents the space between both. The figure depicts the random movement of the tip (in yellow in the figure), which is biased by the VEGF gradient (chemotaxis) and by the adhesivity gradient (haptotaxis). The vessel is then assumed to be the set of lattice sites visited by the tip in its random motion (black spots).
evolution of the system are defined in a somewhat arbitrary way. The novelty of the model presented by Anderson & Chaplain [AC] rests on the way in which these rules are defined 9 . The starting point of the method presented in [AC] is a continuous, PDE model for EC motility. This model incorporates diffusion, chemotactic movement in response to a signalling cue, and haptotaxis (i.e. migration up adhesivity gradients which, in the present case is assumed to be proportional to the gradient of extracellular matrix). The model is given by:
9 There exist some precedents for the model proposed by Anderson & Chaplain [AC] . For example, there is a Monte Carlo method for solving the diffusion equation based on discretising the Laplace operator using an Euler scheme, interpreting the corresponding coefficients as transition probabilities and generating an ensemble of random walk trajectories and averaging over that ensemble to produce the solution [LB] .
In these equations, n is the density of ECs, c is the concentration of TAF (chemotactic signal) and f is the concentration of extracellular matrix proteins 10 the second term on the right hand side of the first equation corresponds to the chemotactic response to the signalling cue, c, whereas the thrid term corresponds to haptotactic response to gradients of extracellular matrix, f . Furthermore, this model assumes that the extracellular matrix is both degraded and diposited by the ECs. TAF is uptaken by the ECs.
The next step in Anderson & Chaplain is discretising the PDE in Eq. (3.1) using Euler finite difference scheme, which involves discretising the domain where the model Eq. (3.1) is solved as a square lattice of a given mesh size h. They further discretise the equation in the time domain by discrete increments k:
where the coefficients P i depend on the values of c and f on the lattice site l, m and in the corresponding first neighbour in a way such that P i grows with the difference between them. Now, similarly to what is done in the Monte Carlo solution of the diffusion equation, Eq. (3.2) is reintrepreted as a Master Equation and the coefficients P i as the transition probabilities for the tip of the vessel to move from site l, m to the corresponding first neighbour, i.e. P 0 is the probability per unit time of not moving from l, m, P 1 the probability of moving one lattice site in the x direction, and so on and so forth. In order to generate a network, these rules for tip movement need to be complemented with rules for branching and anastomosis. These processes are not part of the original continuous model as given by Eqs. (3.2) and they have to be added ad hoc. As far as the process of branching is concerned, three rules are taken into account:
(1) The age of the current sprout is greater than some threshold branching age Ψ, i.e., new sprouts must mature for a length of time at least equal to Ψ before being able to branch. (2) There is sufficient space locally for a new sprout to form, i.e., branching into a space occupied by another sprout is not possible. (3) The endothelial-cell density is greater than a threshold level n b , where
l,m . These rules incorporate a number of biologically feasible assumptions, namely, a nascent sprout must reach a minimum size before a new sprout branches off, and branching becomes more frequent as the vessel approaches the tumour.
Anatomosis, i.e. the fusion of two sprouts, is supposed to occur whenever two tips encounter at the same lattice site. Once such fusion has occurred, it is assumed that only one of the two sprouts carry on growing.
In addition an initial profile of c and f is given, which then evoves according to the discretise version of Eqs. (3.1). The initial distribution of TAF, c, is such that its concentration is higher in the tumour side and decreases towards the parent vessel side (see Fig. 1 ). 3.1.1. Results. The first model results obtained by Anderson & Chaplain concern the effect of haptotaxis on the structure of the resulting network. They observe that when haptotaxis is absent (ρ = 0), the sprouts grow towards the tumour in paralel with no anastomosis and minimum branching. In the presence of haptotaxis (ρ = 0) the results are drammatically different: lateral movement of the sprouts ensues and, from very early on, anastomosis occurs. Branching is very much increased with respect to the previous case, specially in the close neighbourhood of the tumour. The rate at which, on average, the network approaches the tumour is smaller when haptotaxis is included than when migration is only due to chemotaxis. Furthermore, for ρ = 0 the leading edge of the network slows down as the tumour is approached, which prevents the completion of angiogenesis, as the network stops advancing before reaching the tumour.
A remedy to such situation, which allows angiogenesis to be completed, is the introduction of EC proliferation. It is assumed that EC proliferation occur at regular intervals after an initial transient has lapsed during which there is no proliferation (as observed experimentally). Anderson & Chaplain [AC] assume that this has the effect on their model of asynchronously (i.e. at different times for each sprout) increasing the length of each sprout by one lattice space.
Reinforced random walk models.
Closely related to the model described in Section 3.1, there is a class of individual-based of angiogenesis models based on the concept of the reinforced random walks [OS] . Originally introduced in a biological context as model for biological dispersal [OD] , these models assume that the random walker diposits or consume some substance whose concentration regulates the transition probabilities. In the case of the model discussed in the previous section, these substances would correspond to fibronectin and TAF, respectively
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. The starting point of this type of models is the stochastic Master Equation.
For example, in one dimension [SW] :
Here we assume a one dimensional grid, where the poisition of the EC cell is given by x = nh, h being the lattice space. P n (t) is the probability of finding an EC at position x = nh at time t. τ ± n (W ) is the probability per unit time of, being at x = nh, moving to (n + 1)h and (n − 1)h, respectively. These transition rates are modulated by the control substances, denoted by W .
By making the assumption that the decision of when to jump is taken independently of the decision of where to jump [OS] , the diffusion limit:
can be taken, yielding a Fokker-Planck-like equation [SW] :
11 The reader is reminded that the model by Anderson & Chaplain [AC] is not a reinforced random walk in the strict sense.
where P is now to be interpreted as the density of ECs at position x at time t. In these models, the connection between the microscopic properties (i.e. the behaviour of individual ECs) and the macroscopic behaviour (i.e. the evolution of the density of ECs), as given by Eq. (3.4), is via the transition rate τ (W ) and this is the obejct that this sort of approach aims to model.
Usually, these transition rates are modelled so as to reproduce a given macroscopic behaviour. For example, if the view that ECs undergo simple diffusion, chemotaxis and haptotaxis (i.e. the corresponding transport coefficients are constant) is adopted, a possible way of chosing τ (W ) is:
where c is the concentration of TAF and f , the concentration of fibronectin. χ 0 and ρ 0 are the chemotactic and haptotactic coefficients, respectively. It is possible to incorporate more complex assumptions. For example, if we assume that ECs move in response to simple chemo-and hapto-taxis, but instead of simple diffusion, they are supposed to diffuse through a porous medium, the corresponding transition rate reads [SW] :
In the particular case of the model presented by Sleeman & Wallis [SW] , Eqs. (3.5) is the model of choice. Sleeman & Wallis present individual-based simulations of a random walk in 2 and 3 dimensions with the transition rates determined by Eqs. (3.5). In general, angiogenesis models based on the reinforced random walk concept do not incorporate cell proliferation (note that Eq. (3.4) describes the evolution of a conserved density). Therefore, they do not lead to successful angiogenesis (see discussion in Section 3.1), however they are expected to produce useful insights on the migration of ECs under tactic stimuli. This is the case with the model presented in [SW] . Otherwise, their results are very similar to those discussed by Anderson & Chaplain in [AC] . Where haptotaxis is not present, sprouts move parallel to each other, thus preventing anastomosis and the formation of a connected network. Consideration of haptotaxis remediates this situation.
3.2.1. Off-lattice models of angiogenesis. An interesting generalisation of the reinforced random walk model of angiogenesis (in its proto-network formation stage) was presented by Planck & Sleeman [PSa] . Their model, which could be dubbed an off-lattice reinforced random walk, tries to unify the approach of Stokes & Lauffenburger [SL] with individual-based models such as those discussed in Sections 3.1 and 3.2. The model by Stokes & Lauffenburger [SL] is a model for the movement of ECs in two dimensions under chemotactic stimulus. The model is formulated in terms of a (system of two) stochastic differential equation(s) for the two components of the velocity of an EC. Both the drift and the (white) noise terms depend on the gradient of TAF.
The model developed in [PSa] is too a model for the random variation of EC velocity in two dimensions. Their basic assumption is that the modulus of the velocity and its direction vary independently from each other. It is further assumed that the modulus of the velocity is a constant, which we denote by s. This reduces the problem to study the biased random walk of a particle on the surface of the unit sphere. A model, i.e. the equivalent of the function τ (W ) , is proposed for the probability per unit rate of the velocity vector to turn clockwise and counter-clockwise. The model they propose incorporate chemo-and haptotaxis by introducing two bias directions, parallel to the direction of the gradient of TAF and adhesivity, respectively, in their model transition probability
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. Similarly to what is done in the two models previously described they supplement the EC migration model with rules for branching and anastomosis. They further assume that, at high TAF concentrations, ECs become desensitised so that they are not able to detect gradients of TAF, i.e. there is no bias direction in the transition probability for the orientation of the velocity vector.
Planck & Sleeman simulations show how each of the factors included influences the model and then proceed to make a comparison with the results obtained in lattice-based simulations [PSa] . In particular, they compare to the models presented in [AC, SW] , which we have discussed in Sections 3.1 and 3.2. To summarise, the results of the off-lattice simulations exhibit qualitative agreement with their lattice-based counterparts, specially those regarding the role of haptotaxis in producing a functional network in which the different vessels fuse to form arcades through which, at a later stage, blood may flow. There are, however, some significant differences in the behaviour of their off-lattice model, namely, the effects of increasing the concentration of fibronectin has more severe effects on the latticebased models than on their off-lattice counterpart. It has been shown in [AC, SW] that fibronectin delays the chemotactic movement of EC. Planck & Sleeman show that if the effect of haptotaxis is increased in the lattice-based simulations ECs are not able to separate from the parent vessel and migrate towards the tumour. By contrast, in their off-lattice model, ECs have an intial momentum that, under equivalent circumstances, may allow the ECs to overcome the brake imposed by extracellular matrix.
Models of blood flow and vascular adaptation
So far, we have discussed some examples of individual-based models which, by tracking the movement of a tip EC, produce a model network of proto-vessels. The main outcome of these models is the clarification of how hapto-and chemotaxis combined to produce a network with the approppriate structure to sustain blood flow, although the models described in Section 3 do not explicitely model the problems inherent to blood flow through complex structures such as their resulting networks.
12 Planck & Sleeman [PSa] adopt and generalise a model of a biased circular random walk previously developed in the context of gravitotactic swimming organisms. See [PSa] for references.
However, the properties of blood flow through such networks are a major issue in the overall dynamics of tumour growth and in the elaboration of efficient therapeutic strategies.
There are several intrinsic difficulties in the modelling of blood flow through vascular networks. The first one is the complex nature of blood itself. Blood is far from being a simple, Newtonian fluid. It is a complex suspension of cells and particles with a wide range of characteristic sizes. As a consequence, it exhibits a strong non-Newtonian behaviour. Luckily, it is possible to make a number of approximations that render the problem of computing the blood flow through a complex vascular network workable. The most popular of these approaches consists of assuming that the flow through each vessel can be described by a Poiseuille flow but with an effective viscosity, which may depend on a number of factors, including properties of both vessels and blood [PSb] . Figure 2. Plot of the relative viscosity, µ rel , as a function of the radius of the vessel for various values of the haematocrit. This plot corresponds to a fit from experimental data obtained by Pries et al. [PSb] . This approach has been followed by Pries et al. [PSb] who found that the main contributors to this effective viscosity are the radius of the vessel, R, and the red blood cells contained within a vessel, i.e. haematocrit
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, H, thereby implicitely considering blood as a two-phase fluid: plasma (liquid phase) and haematocrit (erythrocites, i.e. solid phase). Blood flow through a vessel within a microvascular network is thus described by:
The haematocrit is actually defined as the proportion of the total volume of a vessel which is occupied by red blood cells.
whereQ is the flow rate, ∆P is pressure drop between the two ends of the vessel, L is the length of the vessel, µ 0 is the viscosity of plasma, and µ rel (R, H) is the socalled relative viscosity, which is defined as the ration between blood viscosity and plasma viscosity. The dependence of µ rel on R and H is shown in Fig. 2 , where we have plot the analytical fit obtained by Pries et al. from experimental data [PSb] .
We can see that the overall blood viscosity increases with increasing haematocrit, as blood becomes thicker. We can observe, that due to Fahreaus-Lindquist effect [Fu] , viscosity decreases with decreasing vessel radius, until a minimum is reached whereby blood becomes more viscous as radius decreases further.
A further problem when trying to model blood flow through microvascular networks is the interaction between the structure of the network, the influence of the surrounding tissue and blood flow itself. This is a long standing problem in the study of the physiology of the vascular system which relates to fundamental issues of how its function (i.e. providing oxygen and other essential substances to every cell within the organism) and its structure are related [L] . Investigations on these issues go back to D'Arcy Thomson's seminal book [T] and the work of Murray [Mu] , whi hypothesised a design principle for the vascular system whereby it should be organised so as to minimise the energetic cost necessary to run it. Murray further assumed that the main sources of energy dissipation are blood flow and blood's metabolic rate:
where α b is the metabolic rate per unit volume of blood, and, therefore, the second term on the right hand side of this equation represents the energetic cost of the volume of blood contained in a vessel of radius R and length L. The first term corresponds to the energy dissipated by Poiseuille flow. Note that Murray assumes that the viscosity of blood is constant. By minimising D with respect to the radius we obtainQ ∼ R 3 . This dependency of flow rate on the third power of the radius of a vessel in an optimal network is known as Murray's law. Further analysis by Zamir [Z] lead to the realisation that Murray's law yields constant wall shear stress (WSS) throughout the vascular system, which he could check to be a valid prediction against experimental data for the bigger arteries.
Some 20 years after Zamir's work, more data had become available and the predictions of Murray's law had to be reconsidered. Pries et al. [PSc] collected a more complete set of data than the one Zamir was able to obtain, including data for arteries, arterioles, veins, venules and capillaries. Strikingly, when the WSS is plotted against the corresponding physiological pressure the different type of vessels are subjected to, their whole data set collapsed into a sigmoidal-like curve: for bigger vessels the WSS is constant (pressure-independent), consistently with Zamir's analysis, but as we move down the hierarchy of the vascular system, both the WSS and the pressure decrease in such a way that the relation between them fits the aforementioned sigmoidal relationship (see Fig. 3 for an schematic representation).
In view of these results, Pries et al. [PSc] formulated a design principle for vascular beds whereby vascular networks should be organised in such a way that the WSS-pressure relationship adopts the sigmoidal form they have found experimentally. [PSc] . The blue region in the plot correspond to the regions in which data from arterioles, venules and capillaries collapse. The red region corresponds to the region corresponding to arteries and veins.
More recent work on this issue include design principles based on geometrical constraints, such as the network being space-filling [GL] or being generated with an stochastic growth process whose fractal properties match those obeserved experimentally [GB] . Further research has been done on design principles based on minimisation of the energy cost necessary to run the vascular system, including a model able to predict the allometric scaling between metabolic rate and body mass [WB] , and a generalisation of Murray's design principle which, by taking into account the dependency of the blood viscosity on vessel radius and haematocrit shown in Fig. 2 , is able to reproduce the WSS-pressure relationships found both experimentally and theoretically [ABd] .
The design principles described in previous paragraphs represent a static picture and do not take into account another fundamental property of the vascular system: adaptability. The vascular system is not simply a collection of passive pipes, it is under tight regulation to adapt to the changing necessities of the different tissues within the body. In order to achieve that, a number of mechanisms have been developed to act upon the vasculature both acutely, eg transient structural adaptation by means of controlling vessel radius, and cronically, eg remodelling involving vessel pruning and angiogenesis.
Mechanisms of structural adaptation, i.e. changes in vessel radius in response to a number of stimuli, has been proposed and studied at length by Pries et al. [PSd, PSe] . The main assumption is that vessel radius change in time to adapt to signals both from the blood flow itself, so the vascular system will have a general tendency to comply to the structure imposed by a given design principle 14 and from the tissue, eg if some portion of the tissue undergoes hypoxia, it will produce and release signalling cues which will tend to increase the vessel radius so the supply of oxygen 14 In the case of [PSd, PSe] , this design principle consists of the vasculature to adapt itself so that WSS a pressure exhibit a sigmoidal dependency [PSc] .
is locally increased. These two stimuli are referred to as hydrodynamic stimulus and metabolic stimulus respectively. There is a further stimulus, the so-called conducted stimulus, which ensures that the vascular system remains functional upon local adaptation. This stimulus consists of signals sent both up-and down-stream. Last, and to ensure that the system is stable, a global shrinking tendency is assumed, whereby all vessels shrink at a given rate in the absence of signals that prevent them to do so.
4.1. Simulations on complex networks with simple rheology. The picture emerging from this summary is that modelling blood flow through the microcirculation is a daunting task, as blood is not only a complex, non-Newtonian fluid but the network of vessels it flows through is itself a dynamical system which responds to both blood flow and external signals. In view of this, the first attempts on modelling blood flow through vascular networks in cancer were performed on static networks.
In particular, the work by McDougall et al. [MAa] takes as starting point a network generated by the model of Anderson & Chaplain [AC] . The outcome of the simulation of the network formation process is a set of nodes, corresponding to the points where two vessels have fuse to form an arcade, and a connectivity matrix which contains the information of how the nodes are connected. This simulated network is then projected onto a square lattice and the vessels are constructed by selecting at random their lengths (in units of the lattice spacing) and joining the correponding nodes along the edges of the lattice (see Fig. 4 for an schematic representation). Radii of each vessel are also drawn randomly from a uniform distribution. Figure 4 . Schematic representation of the projection of the vascular network on a square lattice. The vessel on the top is assumed to be the parent vessel. A pressure drop is applied between the ends of the parent vessel. This is the only pressure drop assumed. The tumour is assumed to be on the far bottom side of this cartoon.
The basic blood flow simulation technique used in [MAa] , which is shared by most of the works to be discussed later on, is to assume that blood flow through a vessel can be described by Poiseuillle's law. This law (see Eq. 4.1) has the same form as Ohm's law in electrical current. As blood flow and electric current are both under the same type of conservation constrains, it is to possible to map the blood flow problem onto an electric current problem and use Kirchoff's laws to solve it.
McDougall et al. [MAa] make some rather strong simplifying assumptions: they consider blood as a Newtonian fluid with constant viscosity and they consider that the vessel radii do not change. In spite of these assumptions, and as a consequence of the complex structure of the vascular network, they obtain some rather interesting results concerning transport of drugs to the tumour.
To analyse this issue, McDougall et al. first solve for the nodal pressures and elemental flow rates and then inject a substance (i.e. drug) into the upstream end of the parent vessel. At each time step, the amount of drug entering each node is calculate and, by assuming perfect mixing within each node, the new drug concentrations for each outlet vessel are calculated (for the technicalities involved in this calculation the reader is refered to [MAa] ).
The results from simulations of drug transport with continuous infusion reported in [MAa] are as expected: due to its continuous infusion, the drug eventually saturates the capillary netwrok and significant amounts of drug reach the tumour. In fact, after an initial transient where no drug has reached the tumour (corresponding to the transit time for the leading edge of the drug distribution within the network to reach the tumour) the amount of drug being delivered grows linearly with time. As expected, increasing the blood viscosity and decreasing the average vessel radius has the same qualitative effect, namely, reducing the amount of drug being delivered.
Simulations with drug being administered as a bolus injection (i.e. drug being delivered into the inlet of the parent vessel only for a given period of time) appear to produce more interesting results. As it is injected, drug initially propagates through the network very much in the same way as in the continuous infusion case. However, after the bolus injection, fresh clean blood comes in and start diluting the drug within the vasculature. This, combined with high tansit times due to the complex structure of the network, may have important consequences on drug efficiency, specially if, for example, the drug needs to accumulate within the tissue beyond some threshold before becoming effective [MAa] .
Investigations on simple networks with complex rheology.
The results of the model by McDougall et al. [MAa] are a reflection of the complex network structure, due to the symplifying assumptions made on blood rheology (constant viscosity) and structural adaptation (vessel radii held static throughout the simulations).
The models by Alarcón et al. [ABa, ABb, ABc, AO] take the opposite approach: whilst the topology of the network considered is far simpler than the one considered in [MAa] , the model by Alarcón et al. incorporates the complexities involved in blood rheology and vascular structural adaptation.
There is another substantial difference between the models discussed in this section and those formulated by McDougall et al. [MAa, SM, MAb] . Whilst the later ones focus exclusively on the formation of the vascular network and the properties of flux and drug transport, the former ones couple the evolution of the network and blood flow, and the dynamics of the tissue. The basic model as proposed in [ABa] builds up on the empirical description of the relative viscosity as discussed earlier on this Section [PSb] and on the structural adaptation mechanism proposed by Pries et al. [PSd] , with the difference that we are not considering the conducted stimuli. The main aim of this model is to study the effect the complexities inherent to blood flow have on the transport of oxygen to the tissue. This forces the introduction of a factor not taken into account in the model discussed in Section 4.1: the haematocrit. By doing so we can calculate the amount of red blood cells within each vessel of the network shown in Fig.  5 . This network is then projected onto an square lattice (very much in the same way as it is done in [MAa] and discussed in Section 4.1). This information is then used as a spatially extended source of oxygen, which, in turn, by solving the corresponding diffusion equation allows us to calculate the concentration of oxygen on each lattice site (for the tecnical details involved in this, the reader is referred to [ABa] ). Simultaneously, on this lattice, there is a cellular automaton describing the population dynamics of and the competition between normal and cancer cells. This dynamics depends on the local oxygen levels: where the concentration of oxygen is high, cells are likely to proliferate, whereas in those regions where oxygen concentration falls below some threshold, cells are unable to survive. In this way we can analyse how blood flow and vascular dynamics influence the growth of populations of cells. Due to the inclusion of the haematocrit in the model, some consideration to the two-phase nature of blood and to phase separation effects must be given. In the model presented in [ABa] such issues take the form of a number of rules on how the haematocrit is splitted at bifurcations (see Fig. 6 for an schematic representation). These rules are rather simplified and constitute a rough approximation of what is actually happening but they still seem to provide a reasonable description. The rule for haematocrit splitting is divided in two parts, based on the ratio of the velocities of the two daughter vessels. If this ratio is smaller than a given thershold, the haematocrit is splitted so that the ratio between the haematocrits corresponding to each of the daughter vessels equals the corresponding ratio of velocities. If, rather, the velocity ratio is larger than the threshold, due to the so-called plasma skimming effect, all the haematocrit of the parent vessels passes onto the faster branch, whereas the slowest one gets none.
All these ingredients contribute towards a very complex behaviour: blood flow, which determines the distribution of haematocrit and therefore tissue bahaviour, depends, via the viscosity and the structural adaptation mechanism, on the distribution of haematocrit. This coupling is treated in the usual iterative way until some stationarity condition is satisfied. As a consequence of this coupling the distributions of both flow and haematocrit are very inhomogeneous. This, in turn, induces an inhomogeneous oxygen distribution which, in turn, strongly influence the growth properties of the cell populations. This implies that the view usually held whereby wherevere there are endothelial cells there is blood and, therefore, the tissue is going to be well oxygenated, is unlikely to be accurate [ABa] .
These results are likely to have some bearing on the way anti-angiogenic therapy is conceived. This issue was partially addressed in [ABb] . Here, simulations of the model presented in [ABa] are carried out for different vascular densities. It is observed that eliminating vessels does not necessarily leads to smaller tumours. In fact, if the fraction of vessels being eliminated is moderate, a larger tumour burden is sustained by a less dense vasculature with respect to the original (more dense) vasculature. This is caused by the fact that the less dense vasculature produces a more homogeneous distribution of haematocrit and, therefore, as well of oxygen over the tissue, which leads to more cells being able to survive than under the more dense vasclature. Of course, if the fraction of removed vessels is very big, large pockets of hypoxia appear, resulting in smaller tumours than in the "control" case.
4.3. Models incorporating complex vasculature and complex rheology. These main ideas of the models proposed in [MAa, ABa] have been further developed into models which aim to couple the formation and later remodelling of the network with blood flow and structural adaptation. An example of a first step towards such an integrative model is presented by Stephanou et al. in [SM] . This model represents an extension of the model originally formulated in [MAa] in two different directions.
One one hand, Stephanou et al. couple the process of network formation to blood flow introducing shear stress-modulated branching probabilities. The model for network formation considered in [MAa] is essentially the one proposed in [AC] . In [SM] , this model is modified in two ways: the effects of matrix-degrading enzymes secreted by active ECs is explicitely considered, and the branching probabilities are considered to depend upon both the local concentration of TAF and the wall shear stress exerted by blood flow upon a particular vessel. As the network formation process progresses, arcades able to sustain blood flow are formed. Whenever one of these is formed, the simulation solves for the new distribution of nodal pressures and elemental flows, which allows to calculate the WSS acting upon the circulated vessels. This information is, in turn, used to update the branching probabilities. Generally speaking, these probabilities are monotonically increasing functions of both TAF concentration and WSS [SM] .
A comparison between the networks produced by WSS-TAF modulated branching and TAF-only induced branching yields interesting results. From the point of view of the structure the resulting network, the former mechanism appears to produce a more dense network close to the surface of the tumour than the later. Furthermore, the model incoporating WSS-TAF modulated branching leads to a global redistribution of the WSS, as the vasculature evolves continuously. Such WSS redistribution leads to reinforcement of vessel connectivity in other parts of the network and, consequently, modification of the blood flow [SM] . A closer, more quantitative analysis reveals important structural differences between networks generated by WSS-TAF or TAF-only branching. Whereas density increases as the surface of the tumour is approached in both cases, an analysis of the degree distribution of the networks (the amount of nodes connected to a given number of nodes) reveals that, close to the surface of the tumour, the network generated by TAF-only regulated branching is dominated by nodes with two vessels. On the contrary, the network corresponding to the WSS-TAF modulated branching the network is much more interconnected as the proportion of nodes with three and four vessels is similar to that of nodes with two vessels [SM] .
A second difference between the approach by Stephanou et al. [SM] and its counterpart as formulated in [MAa] concerns the consideration of mechanisms for vascular structural adaptation similar to those accounted for in [ABa, ABb] . The networks described in previous paragraphs generated by a WSS-TAF modulated branching probability are homogeneous in the sense that the vessel radii are held constant throughout the simulation. The implementation of these mechanisms are similar to the model described in [ABa] : after the network has been prescribed, as generated by the mechanisms described in [SM] and described in the previous paragraphs, the radii of the vessels is modified accordingly to the structural adaptation mechanisms discused in 4.2.
Once these two issues have been introduced in the model and the corresponding networks have been generated, Stephanou et al. [SM] analyse the transport of drugs to the tumour. As in [MAa] two different regimes are considered: continuous infusion and bollus injection. In the former case, it is observed that the amount of drug that reaches the tumour is significantly higher when structural adaptation is considered. The transit time is reduced. This is due to the fact that structural adaptation increases the average radius, and to the active remodelling of the network which reduces the bypassing effect, typical of very dense networks. In the bolus injection case, the amount of drug that reaches the tumour is greater for the adapted vasculature.
Models of vasculature degradation and vessel normalisation
The models discussed in Sections 3 and 4 assume that the evolution of the network is independent from the dynamics of the tumour. For example, in the models discussed in Sections 3, 4.1 and 4.3 assume that the formation of the network occurs under an static distribution of TAF without any feed-back between network and tissue dynamics.
In this section, we dicuss some modelling approaches to how the dynamics of the tissue alters the dynamics of the corresponding vascular network. As mentioned in Section 2, an outstanding example of this is the destabilasing effect that engulfment by the growing tumour has on the vasculature.
The analysis of these phenomena forces the introduction of a model that explicitely accounts for tumour growth, including the secretion and releasing of angiogenic factors in the absence of oxygen.
5.1. Flow-correlated percolation model of vascular remodelling. Bartha & Rieger [BRa, BRb] have studied the process of vascular remodelling upon engulfment by a growing tumour. Their starting point is a vascular network in two dimensions of a given density with a small tumour in the centre. The vessels are, for simplicity, arranged in a regular square mesh with lattice space a. This vascular mesh is, in turn, embeded in a lattice of smaller lattice space, which sustains the growth .of the tumour. The main aim of the model by Bartha & Rieger is to study how vessel collapse and degradation upon cooption by the growing tumour remodels the vascular network and acts on the dynamics and structure of the tissue.
The dynamics of the model consists of a succesion of Monte Carlo steps, each of them, in turn, consisting of a number of random steps which determine the dynamics of the different elements (vessels and tumour cells) which make up the system.
The dynamics of the tissue is driven by the local concentration of oxygen and the availability of space. At each time (Monte Carlo) step cells divide with a probability ∆τ /T c , where ∆τ is the time step and T c the average proliferation time for cancer cells, provided there is at least one free space in the neighbourhood of the cell attempting division and there is enough oxygen. Otherwise the cell does not divide. Tumour cell death is also controlled by the local concentration of oxygen: if a cell has spent longer than some thresold time span under a threshold oxygen concentration, it is killed with probability 1/2.
Angiogenesis is accounted for in Bartha & Rieger's model in a much less detailed way than the models discussed in previous sections. Bartha & Rieger [BRa] introduce whole vessels between two existing ones depending on several factors. TAF concentration must exceed a threshold value. Furthermore, no cancer cell can be sitting in the path to be occupied by the new vessel. Last, the distance between the ends of the new vessel must not exceed a maximum number of lattice spaces. If these three conditions are satisfied, a new vessel is introduced between to circulated vessels with probability ∆τ /T e , where T e is the estimated proliferation time of ECs. Vessels are also allowed to increase their radii provided the local concentration of TAF exceeds a given threshold. Then the radius of the vessel is increased by a given amount with probabily ∆τ /T e , provided the radius does not exceed a maximum value. Vessel collapse occurs upon engulfment by the growing tumour. As summarised in Section 2, vessel co-option triggers a process of vessel dematuration which render the vessel more suscpetible to collapse. Bartha & Rieger model this process by letting a vessel to be removed from the network with probability ∆τ /T collapse if the vessel is sorrounded by cancer cells and the wall shear stress is below a certain threshold. Vessels are also assumed to regress if they have spent longer than a threshold time span under low oxygen concentration
15
. The distibutions of TAF and oxygen in the model by Bartha & Rieger [BRa] are introduced in a phenomenoligical way. Cancer cells are assumed to be sources of TAF (regardless the concentration of oxygen), the concentration of TAF being defined by:
where the summation is over the locus of lattice sites, r , occupied by tumour cells. The function f (x) = (R T − x)/N for x ≤ R T and f (x) = 0 otherwise. N is a normalisation function chosen so that r f (| r|) = 1. The oxygen concentration is defined in a similar way:
where now the summation is over the locus of all lattice sites occupied by circulated vessels. The function g(x) = (R O − x)/N for x ≤ R O and g(x) = 0 otherwise. N is a normalisation function chosen so that r g(| r|) = 1. The constants R T and R O represent the diffusion lengths of TAF and oxygen, respectively
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. Due to the presence of vessel collapse and regression not all the vessels are circulated: only those which are conneted by an uninterrupted path to both the inlet and outlet of the network are. Hence, after each Monte Carlo step, such vessels need to be identified 17 . Once, this has been done the nodal pressures and elemental flows and WSS are computed using Kirchoff's laws. Bartha & Rieger further assume that blood is Newtonian and consider constant viscosity.
5.1.1. Results. Bartha & Rieger [BRa] obtain a number of interesting results. The first one concerns the structure of the network and the tumour. Their model is able to reproduce experimental results in melanoma whereby the density of vessels in the interior of the tumour is reduced, as a consequence of vessel remodelling upon vessel co-option, with the remaining vessels having large radii. They also observe that the density of vessels greatly increases towards the edge of the tumour. As far as the tumour morphology is concerned, they observe, due to the extensive remodelling and pruning of the network, equally extensive necrotic regions in the centre of the tumour, again in agreement to observations in melanoma.
A most inetresting conclusion of Bartha & Rieger investigations [BRa, BRb] is the fact that the resulting structure of the vascular network in the interior of the tumour is a direct consequence of the fact that the pruning of the network upon engulfment by the tumour is coupled to the blood flow. If vessels were removed in a purely random fashion, due to fundamental theorems in percolation theory [CM] , the interior of the tumour would be either completely deprived of or totally full of vessels. Only for a very particular value of the removal probability (corresponding 15 Recall that vessels may be uncirculated and, consequently, carrying no oxygen. 16 The functions f and g are linear approximations to the proper (exponential) propagator of the diffusion equation. In this sense, Bartha & Rieger [BRa] are ignoring that oxygen is being consumed by the cells.
17 Technically speaking, this is achieved by computing the bipartite component of the associated network.
to the critical value of the percolation transition) it would be possible to obtain an intermediate vascular density. The fact that the removal probabilty depends upon the WSS is of basic importance to obtain a more realistic morphology: pruning the vessels with lower WSS deviates the flow through a increasingly smaller number of bigger vessels where the WSS exceeds the removal threshold.
A further interesting observation is the fact that, due to the spatial and temporal inhomogeneities of the vascular dynamics, the microvascular density is not a particularly informative index as to what is going to be the future evolution of the tumour. The initial vascular density, instead, seems to produce more interesting predictions [BRa] .
5.2. A multiscale model of the combination of anti-TAF and chemotherapy. As it has been mentioned in the Introduction, in spite of soundness of the anti-angiogenic approach to treating solid tumours and its early success both in vitro and in animal experiments, its failure in clinical trials has triggered the investigation as to why anti-angiogenic therapy has not fared as well as expected and possible ways to salvage the considerable amount of effort and resources invested in it.
One of these approaches consists of trying to exploit the phenomenon of vessel normalisation to try and combine anti-angiogenic and conventional chemo-or radiotherapy [Jb] . In Section 2, we have mentioned that, due, at least in part, to the high concentration of angiogeneic factors tumour vasculature is not allowed to mature properly as its normal counterpart does. As a consequence, it is now believed that anti-angiogenic drugs acts as stabilisers of the abnormal vasculature generated by tumour-induced angiogenesis: under the action of such drugs, the vascular network is prunned, vessels have a more normal-looking structure, as blood flow does. Oxygen transport to the tissue is thus similarly normalised and, therefore, becomes more evenly distributed (see the review by Jain [Jb] and references therein). As hypoxia is a well-known factor promoting resistance to conventional therapy 18 , combination of anti-angiogenic therapy, which appears to remediate hypoxia within the tissue, and conventional therapy should produce improved therapeutic outcome.
Such results are partially hinted by the simulation results presented in [ABb] , where moderate pruning of the vessel network leads to a more homogeneous oxygen distribution to the benefit of the tumour, which is then able to grow bigger than under a more dense vasculature, although a more in-depth investigation is needed. To this end, Alarcón et al. [AO] present a generalisation of the multiscale model formulated in [ABc] .
The model formulated in [ABc] is a multiscale model of vascular tumour growth, which couples within an integrated framework models for cell behaviour (i.e. models of how extracellular oxygen modulates cell-cycle progression, apoptosis and VEGF secretion), models for the competition between normal and cancer cells (i.e. a cellular automaton model which accounts for cell-to-cell interactions and space limitations), and a model for blood flow, structural adaptation (coupled to dynamics of the tissue via VEGF) and oxygen transport
19 . The original model has subsequently been subject to several improvements in issues concerning the inclusion of drug transport and delivery to the tissue [BA] and cell movement [BOa] .
In [AO] , this modelling framework is further developed to account for different states of vessel maturation in terms of whether they are engulfed by the tumour and the local concentration of VEGF, which are the two factors that according to the discussion in Section 2 determine the maturation status of a vessel. According to these factors we classify the vessels in two types: NORMAL and CO-OPTED. These two types of vessels adapt according to different adaptation mechanisms. The normal vessels behave according to the general principles for structural adaptation as per the model of Pries et al. [PSe] 20 and discussed in Section 4. The behaviour of the CO-OPTED vessels depend, in turn, on the local levels of VEGF. If the level of VEGF exceeds some threshold value vessels adapt according to an angiogenic mechanism [ABc] , whereby vessel adaptation is affected by the hydrodynamic, metabolic and shrinking tendency stimuli as discussed in Section 4 with the intensity of the metabolic stimulus depending on the concentration of VEGF. If, on the contrary, the local concentration of VEGF falls below its threshold the vessel adapt according to the collapsing mechanism: vessels collapse at rate η, with collapse being opposed by the hydrodynamics stimulus 21 [AO] . Thus, the algorithm to determine vessel behaviour is as follows:
(1) All vessels are initially labelled NORMAL.
(2) The numbers of cancer and normal cells within one lattice site distance from the vessel are counted. If the former exceed the latter the vessel is termed CO-OPTED, otherwise it remains NORMAL. Vessel co-option is reversible, i.e. if this condition ceases to hold, a co-opted vessel is re-labelled NORMAL. (3) Normal vessels undergo structural adaptation according to the normal structural adaptation mechanism as proposed in [AO] (4) Co-opted vessels undergo structural adaptation according to the coopted adaptation mechanism if the local concentration of VEGF is below its threshold value. Otherwise, they adapt according to the angiogenic adaptation mechanism.
It must be noted that angiogenesis is not explicitely included in this model: the angiogenic adaptation mechanism refers only to the increase in the intensity of the adaptation to metabolic demands on the part of the tissue when as the concentration of VEGF becomes bigger.
Anti-angiogenic therapy in this model is assumed to take the form of an antibody against the VEGF receptor (VEGFR): this drug binds to the receptor but does not elicit any cellular response. In the model being discussed here [AO] , this is taken into account within intesity of the metabolic stimulus, reducing the "effective" concentration of VEGF. Cytotoxic drug is introduced in the same way as in [BOb] : it is assumed that the cytotoxic drug acts only on cells that are proliferating. The cells in a quiescent state due to lack of oxygen are immune to it.
5.2.1. Results. This model reproduces the main experimental results in spite of the fact that angiogenesis is not explicitely included, only modulation of the adaptation mechanism by the concentration of VEGF.
The model studies the behaviour under two bolus injections of anti-angiogenic and cytotoxic drugs, respectively. The application of the anti-VEGFR antibody leads to a more homogenous distribution of oxygen, as reflected by the reduction of the population of cells under hypoxic stress
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. Such reduction in the size of the hypoxic pockets within the tissue starts shortly after the application of the bolus injection, and after a given time span during which the size hypoxic population stays low, the size of hypoxic pockets recovers to a size comparable to its size previous to the anti-VEGFR injection. In agreement with the clinical observations the number of cancer cells killed by the injection of anti-VEGFR antibody is very small [AO] .
The reduction of the size of the quiescent population after the bolus injection of anti-VEGFR antibody implies that the efficiency of the cytotoxic drug is increased if applied within this period of time. This behaviour is identified with the existence of the so-called window of opportunity. In fact, if the cytotoxic drug is administered either simultaneously with the anti-VEGFR antibody or after the window of opportunity has been closed, the combination does not yield superior results than the application of the cytotoxic drug on its own [AO] .
Models with a dynamic coupling between angiogenesis and vascular adaptation
The last two models we consider in this review consist of two different attempts to model the dynamical coupling between blood flow, vascular adaptation and angiogenesis [MAb, OA] . 6.1. A model for dynamic adaptive tumour-induced angiogenesis. The model presented by McDougall et al. in [MAb] constitutes a further step forward with respect to [SM] , as it incorporates dynamic coupling between vascular adaptation and network formation, rather than adapting an already generated network.
This raises a series of technical issues, mostly concerning how to achieve an efficient scheme for time stepping. This issue is, in fact, ubiquituous in the simulation of multiscale systems which, in a naturl way, exhibit manifold time scales. Given that, in the present case, the time scale for EC migration and network formation (of the order of days) is much bigger than the time scale for netwrok perfusion (of the order of minutes). An ideal scenario would involve two simulation time steps: one for the migration/network formation process, and another, much finer one for the blood/flow remodelling. This ideal scenario would then simulate network formation using the former time step, stop the simulation whenever a new arcade is formed, switch to the shorter time step, remodel the network accordingly, and then switch back to the longer time scale [MAb] . Unfortunately, in the case of the model of McDougall et al. [MAb] , this becomes prohibitingly time consuming, as more and more anastomoses form as the vasculature approaches the tumour. Given these restrictions, McDougall et al. decided to flow and adapt the network at regular intervals of intermediate duration (shorter than the naturally corresponding to EC migration but longer than the characteristic perfusion times) until it reaches an steady state.
The main elements of the model, apart from the dynamical coupling between angiogenesis and vascular adaptation, most notably the inclusion of WSS-dependent branching, were already present in [SM] and discussed in Section 4.1. However, the extensive simulations carried out in [MAb] concerning the sensitivity of the system to various biochemical and physical factors produce a number of interesting results which we proceed to summarise.
6.1.1. Results. One of the most relevant results of the model presented in [MAb] concerns the role played by the WSS-dependent branching. In general, this type of flow dependent branching enforces dilated anastomoses to appear earlier (i.e. in a more proximal position) than VEGF-only-driven branching. In addition, this process is positively reinforced, yielding to more branching and to the accummulation of more, bigger proximal vessels. All these factors contribute towards posing important barriers to the delivery of both nutrient and drug to the tissue. In fact, it is shown that increasing the sensitivity of the branching process to the levels of WSS leads to an increase of the rate of branching in proximal regions, leading to the creation of a capillary shunt, which would seriously hinder delivery of drug and nutrient to the tumour. Making branching more robust to WSS yields, on the contrary, a more dendritic pattern of vessels which would lead to a more fluid pattern of drug and nutrient delivery.
According to results presented in [MAb] , vascular adaptation would also have an important role in drug delivery and nutrient supply. Transport in adapted vasculatures appear to be mostly dominated by a small 23 number of vessels which sustains most of the flow. It so happens that most of the so-called brush border, i.e. a region in the proximity of the tumour characterised by exhibiting a vascular density much bigger than that observed in the proximal regions, are narrow and poorly perfused. This implies that most of the injected drug finds its way back into the circulation without actually reaching the tumour.
McDougall et al. [MAb] also study the influence of some biochemical parameters on drug and nutrient delivery, specially the effect of varying the haptotactic sensitivity of EC. Simulation results indicate that a reduction of the haptotactic sensitivity leads to a vascular morphology with less branching in the proximal regions and a more direct, less lateral pattern of EC migration, which leads to a more directed pattern in both vascular morphology and flow. Such effect yields, in turn, to an increased amount of tracer drug being delivered to the tumour. As pointed out by McDougall et al., this is a nice example of how two effects which, at first, do not seem to have much mutual relation happen to be interconnected, and how mathematical modelling can help to reveal such unevident couplings.
6.2. A multiscale approach to adaptive angiogenesis. Whereas the model formulated by McDougall et al. [MAb] relyis on a predetermined gradient of TAF for network formation without considering any coupling between dynamics within the tissue and the evolution of the network, the model considered in this Section, due to Owen et al. [OA] , constitutes the first attempt to a genuinely multiscale model of angiogenesis, where the formation of the vascular network and tumour growth are coupled via oxygen transport to the tissue and secretion of TAF on the part of tumour.
The backbone of this model consists of the multiscale model formulated in [ABc] and the model of cell migration considered in [BOa] . The multiscale model has been briefly summarised in Sections 4.2 and 5.2 and, therefore, will not be dicussed any further. The model presented in [OA] is not under a network of fix topology, but under an arbitrary network which evolves in time according to two main factors, namely, angiogenesis due to signalling cues released by regions within the tumour under hypoxic stress, and remodelling (pruning) of the network due to blood flow-related factors, mostly WSS. In addition to survival signals from mural cells, ECs receive vital signals from the blood flow. It is believed that WSS plays a main role as a transductor of these signals [RY] . Thus, the model by Owen et al. assumes that if the WSS within a vessel is below some threshold value, the vessel is removed from the network. This removal is not instantaneous: WSS must be below its threshold for a given time span before the vessel is actually removed. Such an element, which is not taken into account in the model by McDougall et al. [MAb] , is reminiscent of the WSS-dependent removal probability mechanism proposed by Bartha & Rieger [BRa] .
In Owen et al. [OA] , EC migration is modelled as a biased random walk (see the models discussed in Section 3), although with some differences with respect previous treatments [AC, SW, PSa] . EC migration is controlled by several factors. Owen et al. assume, as it is standard, that EC migration is biased towards sites where the concentration of TAF is higher. Two other factors are taken here into account that have not been considered before in previous modelling efforts. The first one of them is that a carrying capacity is introduced whereby if a site is fully occupied the cell cannot move into that site
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. A second factor is an inertia parameter which measures the propensity of cells to stay put. Although the model by Owen et al. [OA] does not account explicitely by adhesivity effetcts, this parameter could be argued to play a similar role.
Branching is assumed to be controlled by the concentration of TAF only, with the branching probability being a monotonically increasing function of TAF levels [OA] . When a sprout branches off, it is uncirculated until it fuses with either another uncirculated sprout or a circulated, mature vessel. Anastomosis has to happen within a given threshold time span for the sprout to survive and become a mature vessel, otherwise the sprout dies off. Once a new arcade has been formed, flow is recalculated for the new network and the new capillary bed is adapted using the adaptation mechanisms discussed previously 25 . 6.2.1. Results. Preliminary simulations are carried out with no angiogenesis and a pressure drop applied between one single inlet and one single outlet vessels to assess the effect of WSS-dependent pruning of the vascular netowrk. These simulations show that this mechanism actually yields to the generation of a backbone 24 Note that in the model by Owen et al. [OA] ECs migrate into space that is already occupied by cells and therefore such excluded volume effects mus be taken into account. 25 Owen et al. [OA] can proceed in this way without running into the time stepping issues discussed in Section 6.1 because the typical size of the networks considered in [OA] is considerably smaller than tose considered in [MAb] .
of dilated vessels which sustain all of the blood flow [OA] . It is shown that pruning due to low WSS levels is increased as the pressure drop between inlet and outlet of the network is reduced.
Simulations performed under no WSS-dependent remodelling show that the final vascular density is influenced by its initial condition, a similar result to that obtained by Bartha & Rieger [BRa] , as well as in the time evolution in the approach towards a steady state: better vascularised tissues reach the steady state earlier than the ones with poorer initial vasculatures. It also seems that the steady state vascular density tends to be larger for tissued with poor initial vascularisation [OA] .
Owen et al. [OA] also analyse the relative importance of the different factors involved in the model. In particular, it is shown that under low chemotactic sensitivity to TAF, new sprouts are unable to form anastomosis thus yielding to irregular development of the angiogenic network, with extensive regions of the tissue being poorly vascularised. Larger chemotactic sensitivity allow sprouts to form anastomosis and, therefore, become circulated, mature vessels. These vessels critically depend for survival of stealing enough flow from the vessels originally in place. This fact, in turn, forces the vascular density to fluctuate around an average which depends on the pressure drop, since this controls the amount of WSS-dependent pruning: whenever that, due to angiogenesis, too many vessels have been generated they become poorly perfused and thereby removed. This, in turn, increases the (local) concentration of VEGF, which triggers angiogenesis.
Conclusions and discussion
The aim of this review is presenting an overview of the modelling approaches to tumour-induced angiogenesis restricting ourselves to individual-based and multiscale models. This review has been organised so that the models discussed at each stage account for the different processes involved in angiogenesis: formation of a backbone of immature vessels, maturation and establishment of blood flow, structural adaptation, and remodelling. All these processes, in practice, occur simultaneously. However, due to the complexity of the process, modelling approaches have proceeded in order of increasing complexity. The state-of-the-art models of angiogenesis [MAb, OA] are starting to approach the modelling of the dynamically coupled process described above.
The way in which the review is organised intends to reproduce the development of the different modelling approaches, from the simpler, although still challenging, situations described in Section 3 to the more complex situations dealt with by the hybrid [MAb] and multiscale [OA] models discussed in Section 6. In this process, the difficulties inherent to each of the levels of complexities have been made explicit and how the approximations made to render the problem tractable at one stage have been tackled in the next step using new approaches and techniques.
In spite of the sofistication of models such as those described in Section 6, there is still a long way to run in terms of turning these models into efficient tools for helping experimentalists to formulate new hypthesis to be tested later on in the laboratory and guiding clinicians in designing effective therapeutical protocols. This issue is a critical one as far as angiogenesis is concerned. Now that it has become evident that anti-angiogenic therapy performs poorly in humans, experimentalists and clinicians are turning to strategies consisting of combining traditional chemo-or radio-therapy with anti-angiogenic agents. For reasons explained above, coming up with efficient schemes will involve understanding such complex issues as the relation between vascular network structure and drug and nutrient delivery. Mathematical models, specially those of the type dealt with in this review, will be more than likely to play a role in such efforts.
However, as the models become more complex to account for more biologically realistic scenarios, their mathematical treatment and numerical implementation become daunting tasks. An example of such difficulties is the time stepping issues discussed in Section 6.1. New numerical and analytical techniques in combination with state-of-the-art computational techniques will have to be used. A particularly promising avenue seems to be along the lines of the hybrid methods proposed by Quarteroni and coworkers to deal with multiscale problems in the circulatory system [FN, QV] . These techniques concentrate the computational effort in spatiallyresolved models of the region of interest with lumped models of the rest of the circulatory system. This approach could be generalised to deal with the complex problems we are dealing with. Simpler models could be used in combination with more complex models focusing on a particular region. For example, in tumour growth there is strong evidence that most of the proliferation within the tumour occurs at the border [BA] . This implies that if we are interested in assessing the effects of a cytotoxic drug, we could focus the computational effort in an accurate, multiscale model of the border and model the rest of the tissue in a less detailed way, provided proper boundary conditions are established.
